Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Biull Eksp Biol Med ; 110(10): 386-9, 1990 Oct.
Article in Russian | MEDLINE | ID: mdl-2177669

ABSTRACT

Administration of Ca-entry blockers with different chemical structure before the braining sessions produced the reduction of memory retention in mice and rats in the one-trial passive avoidance tests. This effect was absent in animals treated immediately after training test. Nootropic drugs piracetam and oxiracetam corrected the retention of memory when injected just after training test. Chronic treatment of rats with increasing doses of the nootropic drugs produced about two-fold tissue-specific elevation in the density of DHP-receptors, associated with L-type Ca-channels in synaptosomal membranes of rat cerebral cortex. Maximal effect was observed in a dose of 10 mg/kg. Diltiazem, administrated in a dose of 10 mg/kg, produced about two-fold decrease in the receptors density measured 24 hrs after the first injection. Oxiracetam (10 mg/kg) completely antagonized the effect of Ca-entry blocker. These data imply that nootropic action of piracetam and oxiracetam is mediated by L-type Ca-channels.


Subject(s)
Avoidance Learning/drug effects , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Memory/drug effects , Psychotropic Drugs/pharmacology , Animals , Cerebral Cortex/drug effects , Diltiazem/pharmacology , Male , Mice , Piracetam/pharmacology , Pyrrolidines/pharmacology , Rats , Rats, Inbred Strains
2.
Brain Res ; 525(2): 319-21, 1990 Aug 20.
Article in English | MEDLINE | ID: mdl-2174714

ABSTRACT

Ca2+ entry blockers riodipine, D-cis-diltiazem and verapamil, when administered i.p. to rats at a dose of 10 mg/kg, produced two-fold decreases in the density of 1,4-dihydropyridine (DHP) receptors in rat cerebral cortex, as revealed by Scatchard plot analysis of radioligand binding made 24 h after the first injection. Thereafter, the number of DHP binding sites increased up to the initial level on day 4 of the treatment. The nootropic drug oxiracetam, when injected simultaneously with Ca2+ channel blockers at a dose of 10 mg/kg, prevented this transient decrease in DHP receptor density in brain. These results can explain the opposite modulation of memory retention by calcium antagonists and nootropic drugs that has been observed previously.


Subject(s)
Calcium Channel Blockers/pharmacology , Cerebral Cortex/metabolism , Pyrrolidines/pharmacology , Receptors, Nicotinic/metabolism , Animals , Calcium Channels , Cerebral Cortex/drug effects , Diltiazem/pharmacology , Dose-Response Relationship, Drug , Kinetics , Male , Nifedipine/analogs & derivatives , Nifedipine/pharmacology , Rats , Rats, Inbred Strains , Receptors, Nicotinic/drug effects , Reference Values , Verapamil/pharmacology
3.
Biull Eksp Biol Med ; 107(6): 711-3, 1989 Jun.
Article in Russian | MEDLINE | ID: mdl-2790169

ABSTRACT

The effect of electroshock (ECS) and piracetam, oxiracetam or N-acetylglycinamide on the passive avoidance conditioned response in rats was studied. The antiemetic effect of the compounds was examined in cats as well. The results obtained allowed us to distinct the nootropic and antiemetic action of the drugs. The substances possessed a similar ability to prevent ECS-induced amnesia. On the contrary, oxiracetam completely prevented the emetic response to morphine at doses 100 times lower and piracetam at doses 10 times higher then those of the opioid. N-Acetylglycinamide had no antiemetic activity. The results obtained show that oxiracetam is 100 times more active in antiemetic test than piracetam. These data comprise the novel properties of nootropic drugs.


Subject(s)
Morphine/pharmacology , Psychotropic Drugs/pharmacology , Vomiting/chemically induced , Amnesia, Retrograde/drug therapy , Amnesia, Retrograde/etiology , Animals , Avoidance Learning/drug effects , Cats , Conditioning, Classical/drug effects , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drug Interactions , Female , Glycine/pharmacology , Glycine/therapeutic use , Male , Piracetam/analogs & derivatives , Piracetam/pharmacology , Piracetam/therapeutic use , Psychotropic Drugs/therapeutic use , Pyrrolidines/pharmacology , Pyrrolidines/therapeutic use , Rats , Rats, Inbred Strains
SELECTION OF CITATIONS
SEARCH DETAIL
...